[Translation] A multicenter, randomized, double-blind, placebo-controlled Phase III study to study the efficacy, safety, and tolerability of oral administration of AK0901 capsules in children with attention deficit hyperactivity disorder aged 6 to 12 years.
评估 AK0901 与安慰剂相比在 6~12 岁 ADHD 儿童受试者中的疗效。评估 AK0901 与安慰剂相比在 6~12 岁 ADHD 儿童受试者中的安全性和耐受性。
[Translation] To evaluate the efficacy of AK0901 compared with placebo in children with ADHD aged 6 to 12 years. To evaluate the safety and tolerability of AK0901 compared with placebo in pediatric subjects with ADHD aged 6 to 12 years.